A simple and low-energy method to prepare loratadine nanosuspensions for oral bioavailability improvement: preparation, characterization, and in vivo evaluation-Reference-Cited by-同舟云学术

A simple and low-energy method to prepare loratadine nanosuspensions for oral bioavailability improvement: preparation, characterization, and in vivo evaluation

Published:2019-09-03 Issue:1 Volume:10 Page:192-201
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Yang Dandan,Li Ruirui,Zhang Fang,Qin Li,Peng Feifei,Jiang Shanshan,He Huiyang,Lu Xiumei,Zhang Peng^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1007/s13346-019-00673-8.pdf

Reference25 articles.

1. Stegemann S, Leveiller F, Franchi D, de Jong H, Linden H. When poor solubility becomes an issue: from early stage to proof of concept. Eur J Pharm Sci. 2007;31:249–61.

2. Linnankoski V-PR, Yliperttula M, Urtti A. Passive oral drug absorption can be predicted more reliably by experimental than computational models-fact or myth. Eur J Pharm Sci. 2008;34:129–39.

3. Hu X, Lin X, Gu Y, Liu Z, Tang Y, Zhang Y, et al. Biocompatible riboflavin laurate long-acting injectable nanosuspensions allowing sterile filtration. Drug Deliv. 2014;21:351–61.

4. Merisko-Liversidge E, Liversidge GG. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev. 2011;63:427–40.

5. El-Hammadi M, Awad N. Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release. AAPS PharmSciTech. 2012;13:53–8.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluplus® as a solubilizing excipient for poorly water-soluble drugs: Recent advances in formulation strategies and pharmaceutical product features;Journal of Drug Delivery Science and Technology;2023-06

2. Development of Co-Amorphous Loratadine–Citric Acid Orodispersible Drug Formulations;Processes;2022-12-16

3. Excipient-free nanodispersions dominated by amphiphilic glycosides for bioavailability enhancement of hydrophobic aglycones, a case of glycyrrhetinic acid with diammonium glycyrrhizinate;International Journal of Pharmaceutics;2022-05

4. Nano Spray-Dried Drugs for Oral Administration: A Review;ASSAY and Drug Development Technologies;2021-10-01

5. Experimental study on the reduction of loratadine particle size through confined liquid impinging jets;International Journal of Pharmaceutics;2020-09